SUPN · Supernus Pharmaceuticals, Inc.
Market Cap
$2.56B
Shares
58.13M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1356576
CUSIP
868459108
13F (30d)
229 filings
226 filers
Visit website
Investor relations